These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 32936972)

  • 21. SHORT syndrome in a two-year-old girl - case report.
    Klatka M; Rysz I; Kozyra K; Polak A; Kołłątaj W
    Ital J Pediatr; 2017 May; 43(1):44. PubMed ID: 28472977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and immunological assessment of APDS2 with features of the SHORT syndrome related to a novel mutation in
    Szczawińska-Popłonyk A; Bernat-Sitarz K; Schwartzmann E; Piechota M; Badura-Stronka M
    Allergol Immunopathol (Madr); 2022; 50(4):1-9. PubMed ID: 35789397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A New Homozygous IGF1R Variant Defines a Clinically Recognizable Incomplete Dominant form of SHORT Syndrome.
    Prontera P; Micale L; Verrotti A; Napolioni V; Stangoni G; Merla G
    Hum Mutat; 2015 Nov; 36(11):1043-7. PubMed ID: 26252249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BMP4 loss-of-function mutations in developmental eye disorders including SHORT syndrome.
    Reis LM; Tyler RC; Schilter KF; Abdul-Rahman O; Innis JW; Kozel BA; Schneider AS; Bardakjian TM; Lose EJ; Martin DM; Broeckel U; Semina EV
    Hum Genet; 2011 Oct; 130(4):495-504. PubMed ID: 21340693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EXPANSION OF THE SHORT SYNDROME PHENOTYPE IN AN ADULT PATIENT WITH UNILATERAL BASAL GANGLIA CALCIFICATION.
    Salinas-Torres VM; De La O-Expinoza EA; Salinas-Torres RA
    Genet Couns; 2016; 27(4):479-483. PubMed ID: 30226966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lineage switch from acute myeloid leukemia to B-lymphoblastic lymphoma with an acquired PIK3R1 loss-of-function mutation.
    Aldulescu M; Leuer K; Jennings LJ; Yap KL; Gong S
    Am J Hematol; 2023 Jan; 98(1):E1-E3. PubMed ID: 36288429
    [No Abstract]   [Full Text] [Related]  

  • 27. Short telomere syndromes cause a primary T cell immunodeficiency.
    Wagner CL; Hanumanthu VS; Talbot CC; Abraham RS; Hamm D; Gable DL; Kanakry CG; Applegate CD; Siliciano J; Jackson JB; Desiderio S; Alder JK; Luznik L; Armanios M
    J Clin Invest; 2018 Dec; 128(12):5222-5234. PubMed ID: 30179220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrahematopoietic manifestations of the short telomere syndromes.
    Schratz KE
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):115-122. PubMed ID: 33275732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline IKAROS mutation associated with primary immunodeficiency that progressed to T-cell acute lymphoblastic leukemia.
    Yoshida N; Sakaguchi H; Muramatsu H; Okuno Y; Song C; Dovat S; Shimada A; Ozeki M; Ohnishi H; Teramoto T; Fukao T; Kondo N; Takahashi Y; Matsumoto K; Kato K; Kojima S
    Leukemia; 2017 May; 31(5):1221-1223. PubMed ID: 28096536
    [No Abstract]   [Full Text] [Related]  

  • 30. Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia.
    Watanabe-Smith K; Tognon C; Tyner JW; Meijerink JP; Druker BJ; Agarwal A
    Leukemia; 2016 Sep; 30(9):1950-3. PubMed ID: 27118405
    [No Abstract]   [Full Text] [Related]  

  • 31. Metabolic Profiling as an Approach to Differentiate T-Cell Acute Lymphoblastic Leukemia Cell Lines Belonging to the Same Genetic Subgroup.
    Alabed HBR; Pellegrino RM; Buratta S; Lema Fernandez AG; La Starza R; Urbanelli L; Mecucci C; Emiliani C; Gorello P
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel SLC12A1 gene mutation associated with hyperparathyroidism, hypercalcemia, nephrogenic diabetes insipidus, and nephrocalcinosis in four patients.
    Wongsaengsak S; Vidmar AP; Addala A; Kamil ES; Sequeira P; Fass B; Pitukcheewanont P
    Bone; 2017 Apr; 97():121-125. PubMed ID: 28095294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia.
    Meijerink JP
    Best Pract Res Clin Haematol; 2010 Sep; 23(3):307-18. PubMed ID: 21112032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does TAL-1 deletion contribute to the high incidence of T-cell acute lymphoblastic leukemia in South Indian patients?
    Sudhakar N; Nirmala K; Rajalekshmy KR; Rajkumar T
    Asian Pac J Cancer Prev; 2008; 9(1):127-30. PubMed ID: 18439091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia].
    Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD.
    Yuan T; Yang Y; Chen J; Li W; Li W; Zhang Q; Mi Y; Goswami RS; You JQ; Lin D; Qian MD; Calin S; Liang Y; Miranda RN; Calin GA; Zhou X; Ma L; Zweidler-McKay PA; Liu B; Weng AP; Medeiros LJ; Zhang Y; You MJ
    Leukemia; 2017 Nov; 31(11):2355-2364. PubMed ID: 28280276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-leg syndrome.
    NICHOLS PJ
    Br Med J; 1960 Jun; 1(5189):1863-5. PubMed ID: 14426919
    [No Abstract]   [Full Text] [Related]  

  • 38. The etiologic patho-mechanics of short leg syndrome.
    STOUDER R
    J Natl Assoc Chirop; 1955 Sep; 45(9):36-8. PubMed ID: 13263908
    [No Abstract]   [Full Text] [Related]  

  • 39. Discordant Clinical Course of Vitamin-D-Hydroxylase (CYP24A1) Associated Hypercalcemia in Two Adult Brothers With Nephrocalcinosis.
    Jobst-Schwan T; Pannes A; Schlingmann KP; Eckardt KU; Beck BB; Wiesener MS
    Kidney Blood Press Res; 2015; 40(5):443-51. PubMed ID: 26304832
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.
    Jotta PY; Ganazza MA; Silva A; Viana MB; da Silva MJ; Zambaldi LJ; Barata JT; Brandalise SR; Yunes JA
    Leukemia; 2010 Jan; 24(1):239-42. PubMed ID: 19829307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.